Scholarlink

Introduction <p>Studies evaluating the effect of whole blood (WB) vs. component-based resuscitation accounting for mechanism of injury are lacking. We sought to evaluate the effects of a WB first resuscitation strategy regarding mechanism of injury.</p> Methods <p>This is a retrospective cohort study of trauma patients who received any blood product during resuscitation from January 2016 to November 2021. The primary outcomes were total blood volume utilized within 24&#xa0;h and 30-day mortality. Multivariable gamma regression with a log link was used for blood volume and logistic regression for mortality. A likelihood ratio test evaluated whether injury mechanism modified the treatment effect.</p> Results <p>Between January 2016 and November 2021, 1,013 injured patients received blood products (785 WB-first). We did not detect statistically significant effect modification by injury mechanism for either outcome (interaction <i>p</i> = 0.44 for blood volume, <i>p</i> = 0.25 for mortality). In multivariable gamma regression, WB-first resuscitation was associated with a ratio of mean total blood volume of 0.71 (95% CI 0.55 to 0.90, <i>p</i> = 0.005) relative to components, representing approximately 29% lower utilization. WB-first was not associated with 30-day mortality (OR 0.90, 95% CI 0.48 to 1.71, <i>p</i> = 0.73).</p> Conclusions <p>A WB-first resuscitation strategy is associated with lower blood volume utilized within the first 24&#xa0;h, without statistically significant effect modification by injury mechanism (though clinically meaningful mechanism-specific differences cannot be excluded). The mortality estimate was non-significant across all analytic approaches but varied in direction (OR 0.66 to 1.48) and was sensitive to handling of approximately 30% of patients with incomplete laboratory data. Further studies are needed to determine which populations most benefit from WB-based resuscitation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Whole blood first resuscitation and association of blood product utilization based on mechanism of injury

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月21日

查看全文
  • Jamie Hadley,
  • Jeffrey Conner,
  • Christopher Thomas,
  • Kaysey Llorente,
  • Aaron Gilani,
  • Brian White,
  • Preston Miller III,
  • Andrew Nunn,
  • Gregory Stettler

摘要

Introduction

Studies evaluating the effect of whole blood (WB) vs. component-based resuscitation accounting for mechanism of injury are lacking. We sought to evaluate the effects of a WB first resuscitation strategy regarding mechanism of injury.

Methods

This is a retrospective cohort study of trauma patients who received any blood product during resuscitation from January 2016 to November 2021. The primary outcomes were total blood volume utilized within 24 h and 30-day mortality. Multivariable gamma regression with a log link was used for blood volume and logistic regression for mortality. A likelihood ratio test evaluated whether injury mechanism modified the treatment effect.

Results

Between January 2016 and November 2021, 1,013 injured patients received blood products (785 WB-first). We did not detect statistically significant effect modification by injury mechanism for either outcome (interaction p = 0.44 for blood volume, p = 0.25 for mortality). In multivariable gamma regression, WB-first resuscitation was associated with a ratio of mean total blood volume of 0.71 (95% CI 0.55 to 0.90, p = 0.005) relative to components, representing approximately 29% lower utilization. WB-first was not associated with 30-day mortality (OR 0.90, 95% CI 0.48 to 1.71, p = 0.73).

Conclusions

A WB-first resuscitation strategy is associated with lower blood volume utilized within the first 24 h, without statistically significant effect modification by injury mechanism (though clinically meaningful mechanism-specific differences cannot be excluded). The mortality estimate was non-significant across all analytic approaches but varied in direction (OR 0.66 to 1.48) and was sensitive to handling of approximately 30% of patients with incomplete laboratory data. Further studies are needed to determine which populations most benefit from WB-based resuscitation.